Treatment of infections due to nonsporing anaerobes.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D001927:Brain Diseases / Q000188:drug therapy; D002440:Cefoxitin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010406:Penicillins; D008795:Metronidazole; D002981:Clindamycin; D002440:Cefoxitin